Philip Bright

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M. Folegatti, Katie Ewer, Parvinder K. Aley et al. · The Lancet · 2020 · 2.6K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa

Síle F. Molloy, Cecilia Kanyama, Robert S. Heyderman et al. · New England Journal of Medicine · 2018 · 405 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Occupational asthma due to glutaraldehyde and formaldehyde in endoscopy and x ray departments.

P F Gannon, Philip Bright, Morag H. Campbell et al. · Thorax · 1995 · 164 citations · Full text

Medicine, Internal Medicine, Occupational Health +13

Occupational asthma due to chrome and nickel electroplating

Philip Bright, Sherwood Burge, SP O'Hickey et al. · Thorax · 1997 · 118 citations · Full text

Pharmacy, Toxicology, Hypersensitivity +12

A double‐blind placebo‐controlled study of the effect of inhaled beclomethasone dipropionate for 2 years in patients with nonasthmatic chronic obstructive pulmonary disease

D C Weir, Geraldine Bale, Philip Bright · Clinical & Experimental Allergy · 1999 · 68 citations

Medicine, Pharmacology, Pharmacotherapy +17